MARKET INTRODUCTION
Over-the-counter (OTC) medicines are available in many different types and are good to treat many types of pain. Generally, there are two major types of OTC pain medicines such as acetaminophen (Tylenol) and nonsteroidal anti-inflammatory drugs (NSAIDs). OTC medicines can also help in reducing fevers, headaches, and other common health conditions.
MARKET DYNAMICS
The over-the-counter pain medication market growth is estimated to grow due to the growing production of generic medicines, growing approvals for OTC medicines, growing geriatric population among which incidences of pain is more, and rising product development activities in the pharmaceutical industry. The growing online distribution network by the companies are likely to serve better growth opportunities for the market in the coming future.
MARKET SCOPE
The "Over-the-Counter Pain Medication Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of over-the-counter pain medication market with detailed market segmentation by drug type, route of administration, and distribution channel. The over-the-counter pain medication market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in over-the-counter pain medication market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The over-the-counter pain medication market is segmented based on drug type, route of administration, and distribution channel. Based on drug type, the market is classified as nonsteroidal anti-inflammatory, acetaminophen, salicylates, and others. Based on route of administration, the market is classified as oral, topical, and parenteral. And based on distribution channel, the market is segmented as hospitals and retail pharmacies, online distribution, and hyper and super markets.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Over-the-counter pain medication market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The over-the-counter pain medication market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting over-the-counter pain medication market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the over-the-counter pain medication market in these regions.
MARKET PLAYERS
The report covers key developments in the over-the-counter pain medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from over-the-counter pain medication market are anticipated to have lucrative growth opportunities in the future with the rising demand for over-the-counter pain medication market in the global market. Below mentioned is the list of few companies engaged in the over-the-counter pain medication market.
The report also includes the profiles of key players in over-the-counter pain medication market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GlaxoSmithKline plc.
- Bayer AG
- Pfizer Inc.
- Sanofi
- Boehringer Ingelheim GmbH
- Merck Co. and Inc.
- Johnson and Johnson Services, Inc.
- Takeda Pharmaceutical Company Limited.
- Reckitt Benckiser Group plc
- Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Over-the-Counter Pain Medication Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Drug Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. GlaxoSmithKline plc.
2. Bayer AG
3. Pfizer Inc.
4. Sanofi
5. Boehringer Ingelheim GmbH
6. Merck Co. and Inc.
7. Johnson and Johnson Services, Inc.
8. Takeda Pharmaceutical Company Limited.
9. Reckitt Benckiser Group plc
10. Teva Pharmaceutical Industries Ltd.
11. Novartis AG
12. Mylan N.V
13. Abbott
14. AstraZeneca
15. Sun Pharmaceutical Industries Limited
1. GlaxoSmithKline plc.
2. Bayer AG
3. Pfizer Inc.
4. Sanofi
5. Boehringer Ingelheim GmbH
6. Merck Co. and Inc.
7. Johnson and Johnson Services, Inc.
8. Takeda Pharmaceutical Company Limited.
9. Reckitt Benckiser Group plc
10. Teva Pharmaceutical Industries Ltd.
11. Novartis AG
12. Mylan N.V
13. Abbott
14. AstraZeneca
15. Sun Pharmaceutical Industries Limited